4-cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists

Details for Australian Patent Application No. 2004266227 (hide)

Owner Merck & Co., Inc.

Inventors Whitter, Willie; Sanderson, Philip E.; Butcher, John; Young, Steven D.; Layton, Mark E.; Dieckhaus, Christine; Liverton, Nigel; Phillips, Brian T.; McIntyre, Charles J.; Munson, Peter; McCauley, James A.; Thompson, Wayne

Agent Spruson & Ferguson

Pub. Number AU-A-2004266227

PCT Pub. Number WO2005/019221

Priority 60/495,650 15.08.03 US

Filing date 11 August 2004

Wipo publication date 3 March 2005

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/019221 Priority application(s): WO2005/019221

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266228-Melanin concentrating hormone receptor antagonists

2004266226-Fluid dispensing apparatus